612.36 USD
+3.19
0.52%
At close Mar 27, 4:00 PM EDT
After hours
612.36
+0.00
0.00%
1 day
0.52%
5 days
2.24%
1 month
4.48%
3 months
17.13%
6 months
2.22%
Year to date
15.99%
1 year
-4.95%
5 years
49.44%
10 years
407.47%
 

About: Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Employees: 15,695

0
Funds holding %
of 7,390 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

322% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $3.39M

15% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 55

0% more funds holding

Funds holding: 524 [Q3] → 525 (+1) [Q4]

1.27% less ownership

Funds ownership: 93.97% [Q3] → 92.7% (-1.27%) [Q4]

14% less capital invested

Capital invested by funds: $8.5B [Q3] → $7.35B (-$1.15B) [Q4]

24% less repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 213

60% less funds holding in top 10

Funds holding in top 10: 5 [Q3] → 2 (-3) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$667
9%
upside
Avg. target
$667
9%
upside
High target
$667
9%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
RBC Capital
Ben Hendrix
38% 1-year accuracy
25 / 66 met price target
9%upside
$667
Outperform
Maintained
14 Mar 2025

Financial journalist opinion

Based on 8 articles about CHE published over the past 30 days

Positive
Zacks Investment Research
1 week ago
OPCH vs. CHE: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
OPCH vs. CHE: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
3 weeks ago
OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
OPCH or CHE: Which Is the Better Value Stock Right Now?
Neutral
Business Wire
3 weeks ago
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be acce.
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
Neutral
Seeking Alpha
3 weeks ago
Chemtrade Logistics Income Fund (CGIFF) Q4 2024 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q4 2024 Earnings Conference Call February 28, 2025 10:00 AM ET Corporate Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President and Chief Executive Officer Conference Call Participants Steve Hansen - Raymond James Nelson Ng - RBC Capital Markets Gary Ho - Desjardins Joel Jackson - BMO Capital Markets Zachary Evershed - National Bank Financial Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund Q4 2024 Conference Call. At this time, all lines are in a listen-only mode.
Chemtrade Logistics Income Fund (CGIFF) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
3 weeks ago
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
Neutral
Seeking Alpha
4 weeks ago
Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Mike Witzeman – Chief Financial Officer Nick Westfall – Chairman and Chief Executive Officer, Chemed VITAS Healthcare Corporation Conference Call Participants Michael Murray – RBC Capital Markets Christian Porter – Bank of America Operator Hello, and welcome to the Chemed Corporation Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
4 weeks ago
Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.
Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
Neutral
Business Wire
4 weeks ago
Chemed Reports Fourth-Quarter 2024 Results
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted.
Chemed Reports Fourth-Quarter 2024 Results
Neutral
Business Wire
1 month ago
Chemed Corporation Declares Quarterly Dividend of 50 Cents
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on March 14, 2025, to shareholders of record as of February 24, 2025. This is equal to the dividend paid in December 2024. This represents the 215th consecutive quarterly dividend paid by Chemed in its 53 years as a public company. Listed on the New York Stock Exchange and headquartered in Cinc.
Chemed Corporation Declares Quarterly Dividend of 50 Cents
Positive
Zacks Investment Research
1 month ago
ADUS vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
ADUS vs. CHE: Which Stock Is the Better Value Option?
Charts implemented using Lightweight Charts™